Ziresovir (Synonyms: AK0529; RO-0529) |
Katalog-Nr.GC38582 |
Ziresovir (AK0529;RO-0529) ist ein potenter, selektiver und oral bioverfÜgbarer Hemmer des Respiratory-Syncytial-Virus (RSV)-Fusionsproteins (RSV-F).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1422500-60-4
Sample solution is provided at 25 µL, 10mM.
Ziresovir (AK0529;RO-0529) is a potent, selective, and orally bioavailable respiratory syncytial virus (RSV) fusion (F) protein (RSV F) protein inhibitor. Ziresovir shows anti-RSV activity (EC50=3 nM) and highlights pharmacokinetics in animal species[1].
[1]. Scott SA, et al. Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol. 2009 Feb;5(2):108-17.
Average Rating: 5
(Based on Reviews and 36 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *